Millipore Sigma Vibrant Logo
Attention: We have moved. Merck Millipore products are no longer available for purchase on MerckMillipore.com.Learn More

203642 BMP-4, Human, Recombinant, E. coli

BMP-4, Human, Recombinant, E. coli : FDS (Fiches de données de sécurité), certificats d’analyse (CoA) et de qualité (CoQ), dossiers, brochures et autres documents disponibles.

Synonymes: Bone morphogenetic protein 4 precursor, BMP-2B

203642
Purchase on Sigma-Aldrich

Aperçu

Replacement Information

Tableau de caractéristiques principal

Purity
≥95% by SDS-PAGE

Products

RéférenceConditionnement Qté
203642-2UG Ampoule plast. 2 μg
Description
OverviewRecombinant, human bone morphogenetic protein-4 (BMP-4) expressed in E. coli and purified by proprietary chromatographic methods. BMP-4 is a monomeric protein that belongs to the transforming growth factor-β (TGF-β) superfamily. BMP-4 plays an important role in the development of various organs. It is essential for bone growth and regeneration in periodontal tissue.
Catalogue Number203642
Brand Family Calbiochem®
SynonymsBone morphogenetic protein 4 precursor, BMP-2B
References
ReferencesGiacomini, D., et al. 2006. Endocrinology 147, 247.
Hsieh, P.C., et al. 2006. J. Vasc. Surg. 43, 150.
Kuroda, R., et al. 2006. Arthritis Rheum. 54, 433.
Frank, D., et al. 2005. Chest 128, 590S.
Han, D.K., et al. 2005. J. Periodontol. 76, 2216.
Klosch, B., et al. 2005. Biotechnol. Lett. 27, 1559.
Product Information
FormLyophilized
Quality LevelMQ100
Applications
Biological Information
Purity≥95% by SDS-PAGE
Physicochemical Information
ContaminantsEndotoxin:< 0.1 ng/µg of Bone Morphogenetic Protein-4
Dimensions
Materials Information
Toxicological Information
Safety Information according to GHS
Safety Information
Product Usage Statements
Storage and Shipping Information
Ship Code Blue Ice Only
Toxicity Standard Handling
Storage -20°C
Do not freeze Ok to freeze
Special InstructionsFollowing reconstitution, refrigerate (4°C) for short-term storage or aliquot and freeze (-20°C) for long-term storage. Stock solutions are stable for 2-7 days at 4°C or for up to 6 months at -20°C.
Packaging Information
Transport Information
Supplemental Information
Specifications
Global Trade Item Number
Référence GTIN
203642-2UG 04055977204377

Documentation

BMP-4, Human, Recombinant, E. coli FDS

Titre

Fiche de données de sécurité des matériaux (FDS) 

BMP-4, Human, Recombinant, E. coli Certificats d'analyse

TitreNuméro de lot
203642

Références bibliographiques

Aperçu de la référence bibliographique
Giacomini, D., et al. 2006. Endocrinology 147, 247.
Hsieh, P.C., et al. 2006. J. Vasc. Surg. 43, 150.
Kuroda, R., et al. 2006. Arthritis Rheum. 54, 433.
Frank, D., et al. 2005. Chest 128, 590S.
Han, D.K., et al. 2005. J. Periodontol. 76, 2216.
Klosch, B., et al. 2005. Biotechnol. Lett. 27, 1559.
Fiche technique

Note that this data sheet is not lot-specific and is representative of the current specifications for this product. Please consult the vial label and the certificate of analysis for information on specific lots. Also note that shipping conditions may differ from storage conditions.

Revision20-May-2008 RFH
SynonymsBone morphogenetic protein 4 precursor, BMP-2B
DescriptionRecombinant, human bone morphogenetic protein-4 (BMP-4) expressed in E. coli and purified by proprietary chromatographic methods. BMP-4 is a monomeric protein that belongs to the transforming growth factor-β (TGF-β) superfamily. BMP-4 plays an important role in the development of various organs. It is essential for bone growth and regeneration in periodontal tissue.
FormLyophilized
Purity≥95% by SDS-PAGE
ContaminantsEndotoxin:< 0.1 ng/µg of Bone Morphogenetic Protein-4
SolubilityReconstitute to ≥100 µg/ml in sterile H₂O containing 0.1% HSA or BSA. Further dilutions can be made with aqueous buffers just prior to use.
Storage -20°C
Do Not Freeze Ok to freeze
Special InstructionsFollowing reconstitution, refrigerate (4°C) for short-term storage or aliquot and freeze (-20°C) for long-term storage. Stock solutions are stable for 2-7 days at 4°C or for up to 6 months at -20°C.
Toxicity Standard Handling
ReferencesGiacomini, D., et al. 2006. Endocrinology 147, 247.
Hsieh, P.C., et al. 2006. J. Vasc. Surg. 43, 150.
Kuroda, R., et al. 2006. Arthritis Rheum. 54, 433.
Frank, D., et al. 2005. Chest 128, 590S.
Han, D.K., et al. 2005. J. Periodontol. 76, 2216.
Klosch, B., et al. 2005. Biotechnol. Lett. 27, 1559.